Opportunity ID: 256021

General Information

Document Type: Grants Notice
Funding Opportunity Number: W81XWH-14-NFRP-IIRA
Funding Opportunity Title: DoD Neurofibromatosis Investigator-Initiated Research Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 7
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: May 27, 2014
Last Updated Date:
Original Closing Date for Applications: Jul 24, 2014
Current Closing Date for Applications: Jul 24, 2014
Archive Date: Aug 23, 2014
Estimated Total Program Funding: $6,004,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description: The NFRP Investigator-Initiated Research Award mechanism was first offered in FY96. Since then, 436 Investigator-Initiated Research Award applications have been received, and 112 have been recommended for funding.

The NFRP Investigator-Initiated Research Award supports highly rigorous, high-impact research projects that have the potential to make an important contribution to NF research and/or patient care. Research projects may focus on any phase of research from basic through translational, including preclinical studies in animal models or human subjects, as well as correlative studies associated with an existing clinical trial. The rationale for a research idea may be derived from laboratory discovery, population-based studies, a clinician’s firsthand knowledge of patients, or anecdotal data. Applications must include preliminary and/or published data that is relevant to NF and the proposed research project.

All projects should adhere to a core set of standards for rigorous study design and reporting to maximize the reproducibility and translational potential of preclinical research. The standards are described in Landis, S.C., et al. A call for transparent reporting to optimize the predictive value of preclinical research, Nature 2012, 490:187-191 (www.nature.com/nature/journal/v490/n7419/full/nature11556.html). While these standards are written for preclinical studies, the basic principles of randomization, blinding, sample-size estimation, and data handling derive from well-established best practices in research and should be applied. Projects that include research on animal models are required to submit Attachment 8, Animal Research Plan, as part of the application package to describe how these standards will be addressed. Applicants should consult the ARRIVE (Animal Research: Reporting In Vivo Experiments) guidelines to ensure relevant aspects of rigorous animal research are adequately planned for and, ultimately, reported. The ARRIVE guidelines can be found at http://www.nc3rs.org.uk/page.asp?id=1357.

Research involving human subjects and human anatomical substances is permitted; however, clinical trials are not allowed under this funding opportunity. For more information on clinical trials and clinical research overall, a Human Subject Resource Document is provided on the electronic Biomedical Research Application Portal (eBRAP) system at
https://ebrap.org/eBRAP/public/Program.htm. PIs wishing to apply for funding for a clinical trial should utilize the FY14 NFRP Clinical Trial Award mechanism (Funding Opportunity Number: W81XWH-14-NFRP-CTA).

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Phone: 301-682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

Version History

Version Modification Description Updated Date

Folder 256021 Full Announcement-1 -> NFRP_FY14 IIRA PA_GG.pdf

Packages

Agency Contact Information: Phone: 301-682-5507
Email: help@eBRAP.org
Email: help@eBRAP.org
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
12.420 PKG00197415 May 27, 2014 Jul 24, 2014 View

Package 1

Mandatory forms

256021 RR_SF424_2_0-2.0.pdf

256021 RR_Budget_1_3-1.3.pdf

256021 RR_KeyPersonExpanded_2_0-2.0.pdf

256021 PerformanceSite_2_0-2.0.pdf

Optional forms

256021 RR_SubawardBudget30_1_3-1.3.pdf

2025-07-09T12:51:14-05:00

Share This Post, Choose Your Platform!

About the Author: